Medpace Holdings Financials - Benzinga

Medpace Holdings Inc

MEDPNASDAQ

Trade with Public

Trade with Public

$618.45

-0.43-0.07%

Últ. Act.: Sep 28, 3:40 PM

Panorámica general Noticias Previsión de beneficios Precios objetivoFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

Medpace Holdings Financials

Medpace Holdings (MEDP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook

Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.

Vandana Singh

Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today

Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.

Piero Cingari

PRO
Medpace Holdings Q2 New Business Awards $795.7M Up 28.2% YoY; Resulted In Net Book-To-Bill Ratio Of 1.13x

Benzinga Newsdesk

PRO
Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est

Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805 billion-$2.885

Benzinga Newsdesk

PRO
Medpace Hldgs Q2 EPS $4.25 Beats $3.97 Estimate, Sales $707.331M Beat $687.647M Estimate

Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.25 per share which beat the analyst consensus estimate of $3.97 by 7.05 percent. This is a 37.1 percent increase over earnings of $3.10 per share from the

Benzinga Newsdesk

Earnings Scheduled For July 22, 2026

Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly earnings at $3.45 per share on revenue of $2.35 billion. • Old National Bancorp (NASDAQ:ONB) is projected to report

Benzinga Insights

© 2026 Benzinga | All Rights Reserved